Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2014 by Ohio State University Comprehensive Cancer Center
Sponsor:
Collaborator:
Sanofi
Information provided by (Responsible Party):
Richard Goldberg, Ohio State University Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT01652196
First received: July 25, 2012
Last updated: November 7, 2014
Last verified: November 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)